Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Nurix
Biotech
Sanofi pays $15M for another STAT6 degrader from Nurix collab
Sanofi’s collab with Nurix is continuing to bear fruit, with the pharma securing its second protein degrader from the biotech in a matter of months.
James Waldron
Jun 2, 2025 9:50am
J&J innovator vaults to Valo—Chutes & Ladders
Apr 11, 2025 8:30am
Sanofi pays Nurix $15M upfront for autoimmune degrader
Apr 2, 2025 8:10am
Flagship vet plants CEO roots at Pharming—Chutes & Ladders
Jan 24, 2025 8:30am
Roche, Vir, Neurocrine & more—Chutes & Ladders
May 31, 2024 8:30am
Gilead dives deeper into Nurix protein degrader collab
Apr 2, 2024 9:10am